The 'atypicality' of antipsychotics: a concept re-examined and re-defined.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 197, doi. 10.1038/nrd2806
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 3
Results: 24
1
2
Portfolio analysis and R&D decision making.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 189, doi. 10.1038/nrd2744
- By:
- Publication type:
- Article
3
Anticancer drugs: Inhibiting hedgehog.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 195, doi. 10.1038/nrd2835
- By:
- Publication type:
- Article
4
Antibacterials: Vive la difference!
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 193, doi. 10.1038/nrd2832
- By:
- Publication type:
- Article
5
Drug metabolism: Seeking the soft spots.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 196, doi. 10.1038/nrd2836
- By:
- Publication type:
- Article
6
Molecular targets for cancer chemoprevention.
- Published in:
- 2009
- By:
- Publication type:
- journal article
7
The FGF family: biology, pathophysiology and therapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
8
The influence of lead discovery strategies on the properties of drug candidates.
- Published in:
- 2009
- By:
- Publication type:
- review
9
Febuxostat.
- Published in:
- 2009
- By:
- Publication type:
- journal article
10
Glycosylation as a strategy to improve antibody-based therapeutics.
- Published in:
- 2009
- By:
- Publication type:
- journal article
11
Obesity: Reversing leptin resistance.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 194, doi. 10.1038/nrd2833
- By:
- Publication type:
- Article
12
Neurodegenerative disease: Reversing defective lysosomal transport.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 194, doi. 10.1038/nrd2834
- By:
- Publication type:
- Article
13
In Brief.
- Published in:
- 2009
- Publication type:
- Abstract
14
Deal watch: Synta and Roche collaborate on anti-inflammatory ion channel modulators.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 184, doi. 10.1038/nrd2839
- Publication type:
- Article
15
Market watch: Specialty pharmaceuticals to provide majority of sales by 2012.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 184, doi. 10.1038/nrd2840
- By:
- Publication type:
- Article
16
Deal watch: Anti-IL-5 antibody attracts Cephalon to agree option for Ception acquisition.
- Published in:
- 2009
- Publication type:
- journal article
17
Ruth McKernan.
- Published in:
- 2009
- Publication type:
- Interview
18
Regulatory Affairs.
- Published in:
- 2009
- Publication type:
- Interview
19
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 175, doi. 10.1038/nrd2844
- Publication type:
- Article
20
Combating the cons of consolidation.
- Published in:
- 2009
- Publication type:
- Editorial
21
Biomarker debate highlights retrospective challenge.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 179, doi. 10.1038/nrd2846
- By:
- Publication type:
- Article
22
Gearing up for follow-on biologics.
- Published in:
- 2009
- By:
- Publication type:
- journal article
23
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 182, doi. 10.1038/nrd2848
- Publication type:
- Article
24
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 186, doi. 10.1038/nrd2849
- By:
- Publication type:
- Article